These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1225 related items for PubMed ID: 23141176

  • 1. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D, Wu M, Ren T, Wan XR, Feng FZ, Huang HF, Yang JX, Shen K, Xiang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C, Fabrini MG, Genazzani AR.
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L, Mazzola S, Marocco F, Ferrero A, Dompè D, Carus AP, Zola P.
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
    Huang X, Lan C, Huang H, Zhang Y, Huang H, Cao X, Huang Y, Guo Y, Wan T, Liu J.
    Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
    [Abstract] [Full Text] [Related]

  • 8. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL, Wu LY, Li XG, Zhang R, Li N, Yao HW.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP, Li B, Wang YT, Liu SH, Zhang YN, Zhang R, Bai P, Li XG, Wu LY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr 25; 53(4):248-256. PubMed ID: 29747270
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 25; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 11. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Oct 25; 95(1):70-6. PubMed ID: 15385112
    [Abstract] [Full Text] [Related]

  • 12. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS.
    Gynecol Oncol; 2001 Jul 25; 82(1):88-93. PubMed ID: 11426967
    [Abstract] [Full Text] [Related]

  • 13. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, Lou G, Li K.
    J Surg Oncol; 2012 Feb 25; 105(2):206-11. PubMed ID: 21815150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L, Colombo N, Zanagnolo V, Landoni F, Bocciolone L, Cárdenas-Rebollo JM, Iodice S, Maggioni A.
    Int J Gynecol Cancer; 2013 Nov 25; 23(9):1647-54. PubMed ID: 24100590
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G, Hasenburg A.
    Gynecol Oncol; 2005 Mar 25; 96(3):658-64. PubMed ID: 15721408
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Mar 25; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 19. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.
    J Surg Oncol; 2002 May 25; 80(1):4-11. PubMed ID: 11967899
    [Abstract] [Full Text] [Related]

  • 20. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 25; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.